Roche Holding (RHHBY)
(Delayed Data from OTC)
$30.47 USD
-0.77 (-2.47%)
Updated Apr 24, 2024 02:20 PM ET
5-Strong Sell of 5 5
D Value C Growth C Momentum D VGM
Average Brokerage Rating
Current ABR | 3.20 |
ABR (Last week) | 3.20 |
# of Recs in ABR | 10 |
Average Target Price | $37.75 |
LT Growth Rate | 2.80% |
Industry | Large Cap Pharmaceuticals |
Industry Rank by ABR | 224 of 252 |
Current Quarter EPS Est: | NA |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 3.20 | 3.20 | 3.20 | 3.22 | 3.22 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/5/2024 | Argus Research Corp. | Research Department | Not Available | Hold |
9/5/2023 | Berenberg Bank | Luisa Hector | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.